Presentation updated OCEAN data

Oncopeptides hosted a webcast on July 8, 2021, at 11:00 (CET) including presentations by CEO Marty J Duvall, CSO Jakob Lindberg, and CMO Klaas Bakker.

Investors, financial analysts and media were invited to participate in the webcast with a QnA session. The presentation was held in English and was recorded.

The recorded webcast is available via the link
https://tv.streamfabriken.com/oncopeptides-pressconference-july-2021

The presentation from July 8, as PDF file, is available below.

FDA safety alert

On July 28, 2021, the US Food and Drug Administration issued a safety alert regarding an increased risk of death associated with Pepaxto® (melphalan flufenamide), in the OCEAN study. To read this alert you may visit the FDA website here.

Patient safety is paramount to Oncopeptides. We are fully cooperating with the FDA as they continue to evaluate the OCEAN data. We will provide additional updates as they become available.

You may also read Oncopeptides’ press release here.

Presentation webcast as PDF and transcript

UPDATED OCEAN TOPLINE RESULTS WEBCAST July 8 2021
pdf, 841 KB
Transcript webcast 2021-07-08 Updated OCEAN results
pdf, 168 KB